Hua Medicine Announces Successful U.S. Phase I Results On Its 2Nd Generation GKA Candidate
SHANGHAI, Nov 30, 2024 - (ACN Newswire) - Hua Medicine (the“Company”, HKEx stock code: 2552) announced today that the Company has successfully completed a Phase I clinical trial on its 2nd generation ...